Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.45 |
| ▸ | ANPEP | P15144 | 7/20 | 0.42 |
| ▸ | RNPEP | Q9H4A4 | 4/20 | 0.42 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.42 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.40 |
| ▸ | LAP3 | P28838 | 4/20 | 0.39 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18870463 | 0.89 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL995721 | 0.85 | SLC7A5 (0.58) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL9100153 | 0.85 | SLC7A5 (0.58) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL29564893 | 0.84 | GABRP (0.48) | SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL24798069 | 0.83 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL76796 | 0.83 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL12345872 | 0.83 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL387310 | 0.83 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL700933 | 0.83 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL13144609 | 0.83 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200325190-A1 | Modification and Compositions of Human Secretoglobin Proteins | APC RESEARCH ASSETS, LLC | 2020-10-15 | — | — | US | claimed |
| US-20190337999-A1 | Modification and Compositions of Human Secretoglobin Proteins | APC RESEARCH ASSETS, LLC | 2019-11-07 | — | — | US | claimed |
| US-10294285-B2 | Modification and compositions of human secretoglobin proteins | CLARASSANCE, INC. | 2019-05-21 | — | — | US | claimed |
| US-20160362462-A1 | Modification and Novel Compositions of Human Secretoglobin Proteins | Therabron Therapeutics, Inc. (US) | 2016-12-15 | — | — | US | claimed |
| US-9394349-B2 | Modification and compositions of human secretoglobin proteins | Therabron Therapeutics, Inc. (US) | 2016-07-19 | — | — | US | claimed |
| CN-105744946-A | Modification and Novel Compositions of Human Secretoglobin Proteins | 希拉布朗治疗有限公司 | 2016-07-06 | — | — | CN | claimed |
| EP-2968449-A2 | MODIFICATION AND NOVEL COMPOSITIONS OF HUMAN SECRETOGLOBIN PROTEINS | Therabron Therapeutics, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014145368-A2 | MODIFICATION AND NOVEL COMPOSITIONS OF HUMAN SECRETOGLOBIN PROTEINS | CLARASSANCE, INC. (US) | 2014-09-18 | — | — | WO | claimed |
| US-20140275477-A1 | Modification and Compositions of Human Secretoglobin Proteins | CLARASSANCE, INC. (US) | 2014-09-18 | — | — | US | claimed |
| US-20210363203-A1 | Modification and compositions of human secretoglobin proteins | APC RESEARCH ASSETS, LLC | 2021-11-25 | — | — | US | disclosed |
| US-20200325190-A1 | Modification and Compositions of Human Secretoglobin Proteins | APC RESEARCH ASSETS, LLC | 2020-10-15 | — | — | US | disclosed |
| US-10676513-B2 | Modification and compositions of human secretoglobin proteins | APC RESEARCH ASSETS, LLC (US) | 2020-06-09 | — | — | US | disclosed |
| US-20190337999-A1 | Modification and Compositions of Human Secretoglobin Proteins | APC RESEARCH ASSETS, LLC | 2019-11-07 | — | — | US | disclosed |
| US-10294285-B2 | Modification and compositions of human secretoglobin proteins | CLARASSANCE, INC. | 2019-05-21 | — | — | US | disclosed |
| US-20160362462-A1 | Modification and Novel Compositions of Human Secretoglobin Proteins | Therabron Therapeutics, Inc. (US) | 2016-12-15 | — | — | US | disclosed |
| US-9394349-B2 | Modification and compositions of human secretoglobin proteins | Therabron Therapeutics, Inc. (US) | 2016-07-19 | — | — | US | disclosed |
| CN-105744946-A | Modification and Novel Compositions of Human Secretoglobin Proteins | 希拉布朗治疗有限公司 | 2016-07-06 | — | — | CN | disclosed |
| EP-2968449-A2 | MODIFICATION AND NOVEL COMPOSITIONS OF HUMAN SECRETOGLOBIN PROTEINS | Therabron Therapeutics, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014145368-A2 | MODIFICATION AND NOVEL COMPOSITIONS OF HUMAN SECRETOGLOBIN PROTEINS | CLARASSANCE, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140275477-A1 | Modification and Compositions of Human Secretoglobin Proteins | CLARASSANCE, INC. (US) | 2014-09-18 | — | — | US | disclosed |